Acumen Pharmaceuticals discovers and develops therapeutics and diagnostics for neurodegenerative disorders.
Business Model:
Revenue: $1.4M
Employees: 11-50
Address: 427 Park St.
City: Charlottesville
State: VA
Zip: 22902
Country: US
Acumen Pharmaceuticals discovers and develops therapeutics and diagnostics for neurodegenerative disorders.
Contact Phone:
+14342971000
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/30/2021
IPO Valuation:
$618M
Ticker Symbol:
ABOS
IPO Price:
$16/share
Amount Raised:
$186M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2020 | Series B | $0 |
BlackRock PBM Capital Group RA Capital Management Rock Springs Capital Sands Capital Ventures BlackRock PBM Capital Group RA Capital Management Rock Springs Capital Sands Capital Ventures |
8/2006 | Venture Round | $0 |
NeuroVentures NeuroVentures |
7/2017 | Grant | 1 | $3.6M |
National Institute on Aging National Institute on Aging |
10/2018 | Series A | 2 | $15M |
PBM Capital Group Sands Capital Ventures PBM Capital Group Sands Capital Ventures |
5/2013 | Series A | $20M | 11/2020 | Series B | 5 | $75M |
BlackRock PBM Capital Group RA Capital Management Rock Springs Capital Sands Capital Ventures BlackRock PBM Capital Group RA Capital Management Rock Springs Capital Sands Capital Ventures |
8/2006 | Venture Round | 1 | $1.5M |
NeuroVentures NeuroVentures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|